Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Assessing the clinical impact of carbapenem pre-authorisation on clinical outcomes in a setting with a high prevalence of extended-spectrum beta-lactamase producing organisms: a focus on the Middle East. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s0140-6736(24)01867-1
10.1016/s0140-6736(24)01867-1 · External reference
10.1016/s0140-6736(21)02724-0
10.1016/s0140-6736(21)02724-0 · External reference
Unresolved reference
External reference
Bacterial resistance to antibacterial agents: Mechanisms, control strategies, and implications for global health
10.1016/j.scitotenv.2022.160461 · 2023 · External reference
10.1016/j.chom.2024.05.015
10.1016/j.chom.2024.05.015 · External reference
Antimicrobial resistance: a concise update
10.1016/j.lanmic.2024.07.010 · 2025 · External reference
Prescribers’ Knowledge, Attitudes and Behaviors on Antibiotics, Antibiotic Use and Antibiotic Resistance in Jordan
10.3390/antibiotics10070858 · 2021 · External reference
10.12788/jhm.2905
10.12788/jhm.2905 · External reference
Unresolved reference
External reference
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
10.1128/aac.01110-18 · 2019 · External reference
A Systematic Review of Antibiotic Resistance Trends and Treatment Options for Hospital-Acquired Multidrug-Resistant Infections
2022 · External reference
10.1126/science.1254163
10.1126/science.1254163 · External reference
10.1007/s002280050727
10.1007/s002280050727 · External reference
Unresolved reference
External reference
Implementation and outcomes of an advanced antimicrobial stewardship program at a quaternary care hospital in the United Arab Emirates
10.1002/jac5.1087 · 2019 · External reference
Criteria Restricting Inappropriate Meropenem Empiricism (CRIME): a quasi-experimental carbapenem restriction pilot at a large academic medical centre
10.1016/j.ijantimicag.2022.106661 · 2022 · External reference
Can’t keep it SECRET: system evaluation of carbapenem restriction against empirical therapy
10.1093/jacamr/dlac137 · 2023 · External reference
10.1093/cid/ciw118
10.1093/cid/ciw118 · External reference
Impact of prolonged carbapenem use-focused antimicrobial stewardship on antimicrobial consumption and factors affecting acceptance of recommendations: a quasi-experimental study
10.1038/s41598-023-41710-4 · 2023 · External reference
10.1093/jac/dkx273
10.1093/jac/dkx273 · External reference
10.1007/s10096-018-3408-2
10.1007/s10096-018-3408-2 · External reference
Impact of Antimicrobial Stewardship Program Intervention Acceptance on Hospital Length of Stay
10.1177/00185787231160436 · 2023 · External reference
10.1086/375818
10.1086/375818 · External reference
P-1762. Assessing the clinical impact of carbapenem pre-authorization in a high ESBL prevalence setting: a focus on the Middle East
10.1093/ofid/ofae631.1925 · 2025 · External reference
Clinical Outcomes of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam in Managing Pseudomonal Infections in Patients Undergoing Renal Replacement Therapy
10.3390/antibiotics13080699 · 2024 · External reference
